Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1888
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.52 USD-7.40%-8.63%+14.64%+134.99%2.35 B USD
1898
NKTR
Nektar Therapeutics - Common Stock
68.32 USD-2.90%-6.60%+13.36%-6.76%2.31 B USD
1903
BHVN
Biohaven Ltd. Common Shares
15.18 USD-2.38%-7.16%+32.00%-10.40%2.29 B USD
1904
MLYS
Mineralys Therapeutics, Inc. - Common Stock
27.59 USD-2.78%-7.14%+15.05%-31.66%2.28 B USD

Frequently asked questions about Pharvaris N.V. - Ordinary Shares

What is the Pharvaris N.V. - Ordinary Shares stock price today?

The current price of Pharvaris N.V. - Ordinary Shares (PHVS) is 35.07. Over the past 24 hours, the stock has changed by 0.00%. Follow the PHVS chart for real-time price dynamics.

What is the stock ticker of Pharvaris N.V. - Ordinary Shares?

Pharvaris N.V. - Ordinary Shares trades under the ticker PHVS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Pharvaris N.V. - Ordinary Shares stock going up?

PHVS has changed by +4.53% over the last week, +12.08% over the last month, and +47.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Pharvaris N.V. - Ordinary Shares have?

As of the latest available data, Pharvaris N.V. - Ordinary Shares has 129 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Pharvaris N.V. - Ordinary Shares stock?

You can buy Pharvaris N.V. - Ordinary Shares (PHVS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Pharvaris N.V. - Ordinary Shares stock?

Investing in Pharvaris N.V. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PHVS chart and related analysis on metatrader.com as part of your research.

News